Skip to content

Odense Androgen Study: Study of Androgens, Body Composition, and Muscle Function in Danish Men

Odense Androgen Study - A Population-Based Study of Androgens, Body Composition, and Muscle Function in 20-29 Year-Old Danish Men

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00150163
Enrollment
800
Registered
2005-09-08
Start date
2002-03-31
Completion date
2008-12-31
Last updated
2007-03-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Diseases

Keywords

Androgens, Bone, Muscle, Estrogens, Fat, Lipid and glucose metabolism

Brief summary

Objective: * To define a reference-population of healthy young men (20-29 years old). * To establish reference-intervals for: 1. Total, bioavailable and free serum androgens (testosterone, dihydrotestosterone, androstenedione) and serum estrogens (estradiol, estrone). 2. Total and free IGF-1. * To study the influence of physical activity, alcohol intake, tobacco and abuse of anabolic steroids on serum levels of androgens. * To identify the androgens (or estrogens) that primarily reflect the following parameters: 1. Muscle mass, muscle strength, muscle power, oxygen uptake, and hematocrit. 2. Bone mineral density and bone metabolism. 3. Total and visceral fat mass. 4. Lipid- and glucose metabolism and glucocorticoid metabolism. 5. Sexual function and quality of life. * To study the modifying effect of birth weight, the AR gene CAG-repeat polymorphism, and the level of IGF-1 on associations between serum androgens and the measures above: Ethics, design and schedule: The local ethic review board approved a population-based, cross-sectional study planned for the inclusion of 800 Caucasian men, 20 to 29 year old, living in the County of Funen. The only exclusion criteria were opioid drug addiction, cancer, and severe chronic disease. A basic questionnaire was mailed to 3000 men, randomly drawn from the Danish Central Personal Registry. Adequately answered questionnaires were returned from 2,199 men, who subsequently received an invitation to participate. Informed consent was obtained from 783 men. The examinations started in March 2002 and terminated in May 2003. Within subject variation was determined for all study parameters in 20 men. The men included matched the men answering the questionnaire on all questionnaire items and demographics. All analyses have been performed, except for the additional serum sex hormone assays, IGF-1 assays and AR gene analyses. A sequential rule-out from the reference population was performed on the following criteria: 1. testicular pathology: bilateral cryptorchidism, varicocele, testes volumina \< 10 ml (each), history of spermatic cord torsion. 2. severe chronic disease. 3. regular medication or abuse of anabolic steroids. 4. body mass index \< 19 kg/m2. 5. safety serum parameters: luteinizing hormone (LH) \<1.0 U/L or \>8.4 U/l, alanine-amino-transferase (ALAT) \>70 U/l and thyrotropin (TSH) \>6.0 mU/l.

Interventions

None listed

Sponsors

Odense University Hospital
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
20 Years to 29 Years
Healthy volunteers
Yes

Inclusion criteria

* Age: 20-29 years * Residence: County of Funen, Denmark

Exclusion criteria

* Opioid drug addiction * Cancer * Severe chronic disease

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026